Extruded Pharmaceuticals Email Formats
Pharmaceutical Manufacturing • 
Wigan, England, United Kingdom • 1-10 Employees
Key Contact at Extruded Pharmaceuticals
Dave Lawton
Member Board Of Directors
Company overview
| Headquarters | Douglas Bank House, Wigan Lane, Wigan, Lancashire WN1 2TB, GB |
| NAICS | 3254 |
| Keywords | Hot Melt Extrusion, Oncology, Cancer Treatment, Chemotherapy, Drug Delivery, Reformulation, Implantable Devices, Local Drug Delivery |
| Founded | 2016 |
| Employees | 1-10 |
About Extruded Pharmaceuticals
Extruded Pharmaceuticals Ltd has developed ChemoSeed®, an implantable device designed to be implanted at the surgical margin of hard-to-treat cancers such as brain and pancreatic cancer as well as other solid tumours such as prostate, breast, bladder, lung and liver cancer. ChemoSeed improves the clinical performance of new and currently available oncology drugs by delivering them directly to the tumour tissue/cancer cells improving efficacy while reducing toxicity/side effects. Our first ChemoSeed is being developed for the localised treatment of brain tumours. This ChemoSeed has completed all preclinical testing and we currently have a sterilised GLP batch available for biocompatibility testing before entering a Phase II registration quality clinical trial in Q4 of 2024. Extruded Pharmaceuticals Ltd have the capability to formulate any API into ChemoSeed and take it from formulation development, through technology transfer, scale-up and GLP toxicity testing onto clinical batch supply for clinical trials.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Extruded Pharmaceuticals has never raised funding before.
South Africa
United States
Frequently asked questions
4.8
40,000 users
